Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). ESSA Pharma's share price for the quarter that ended in Jun. 2025 was $1.7. ESSA Pharma's Shares Outstanding (EOP) for the quarter that ended in Jun. 2025 was 44.39 Mil. Therefore, ESSA Pharma's market cap for the quarter that ended in Jun. 2025 was $75.46 Mil.
ESSA Pharma's quarterly market cap
declined
from Dec. 2024 ($79.46 Mil) to Mar. 2025 ($70.13 Mil) but then
increased
from Mar. 2025 ($70.13 Mil) to Jun. 2025 ($75.46 Mil).
ESSA Pharma's annual market cap
increased
from Sep. 2022 ($80.21 Mil) to Sep. 2023 ($136.27 Mil) and
increased
from Sep. 2023 ($136.27 Mil) to Sep. 2024 ($269.00 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. ESSA Pharma's Enterprise Value for Today is $-100.10 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
ESSA Pharma Market Cap Related Terms
ESSA Pharma Market Cap Historical Data
* Premium members only.
The historical data trend for ESSA Pharma's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, ESSA Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ESSA Pharma Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ESSA Pharma's Market Cap distribution charts can be found below:
* The bar in red indicates where ESSA Pharma's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
ESSA Pharma's Market Cap for the fiscal year that ended in Sep. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ESSA Pharma (EPIX) has a Market Cap of $9.52 Mil as of Aug. 24, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on ESSA Pharma and its competitors.
Is ESSA Pharma's Market Cap too high?
ESSA Pharma's current Market Cap is $9.52 Mil. The Biotechnology industry median Market Cap is 122.31. ESSA Pharma's value of $9.52 Mil is 92.2% below this industry median. Overall, ESSA Pharma has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does ESSA Pharma's Market Cap compare to SLXN and NLSP?
ESSA Pharma's Market Cap of $9.52 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 122.31. ESSA Pharma's value of $9.52 Mil is 92.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 122.31, based on 1,422 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ESSA Pharma's current Market Cap of $9.52 Mil is 92.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on ESSA Pharma and its competitors. For the Biotechnology industry, the median Market Cap is 122.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ESSA Pharma's current Market Cap is $9.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ESSA Pharma stock overvalued right now?
ESSA Pharma (EPIX) has a current Market Cap of $9.52 Mil. The current Market Cap is $9.52 Mil and 92.2% below the Biotechnology industry median of 122.31. ESSA Pharma's overall GF Score™ is 22/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For ESSA Pharma (EPIX), the current Market Cap is $9.52 Mil as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.
22GF Score
Get the complete analysis for EPIX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EPIX has been successfully added to your 
